We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
-9.57%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$1.21B
AUM Growth
+$57.1M
Cap. Flow
+$88M
Cap. Flow %
7.29%
Top 10 Hldgs %
18.29%
Holding
1,231
New
406
Increased
209
Reduced
153
Closed
411
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FPRX
776
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$41K ﹤0.01%
+18,100
New +$76.8K
CHS
777
DELISTED
Chicos FAS, Inc.
CHS
$37K ﹤0.01%
+28,600
New +$98.4K
BRPAR
778
DELISTED
Big Rock Partners Acquisition Corp. Right
BRPAR
$37K ﹤0.01%
287,077
PUMP icon
779
ProPetro Holding
PUMP
$1.36B
$36K ﹤0.01%
+14,200
New +$114K
SRGA
780
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$35K ﹤0.01%
+680
New +$71.1K
OBSV
781
DELISTED
ObsEva SA Ordinary Shares
OBSV
$33K ﹤0.01%
13,821
RFP
782
DELISTED
Resolute Forest Products Inc.
RFP
$32K ﹤0.01%
+25,000
New +$74.7K
CBIO
783
Crescent Biopharma
CBIO
$613M
$31K ﹤0.01%
+134
New +$51.2K
LITS
784
Lite Strategy Inc
LITS
$32.4M
$30K ﹤0.01%
935
+435
+87% +$17.4K
NPKI
785
NPK International
NPKI
$1.17B
$29K ﹤0.01%
+32,500
New +$122K
ALDX icon
786
Aldeyra Therapeutics
ALDX
$95.9M
$28K ﹤0.01%
+11,500
New +$51.7K
HHS icon
787
Harte-Hanks
HHS
$16.8M
$24K ﹤0.01%
15,531
RRD
788
DELISTED
RR Donnelley & Sons Co.
RRD
$24K ﹤0.01%
+25,000
New +$60.5K
XERS icon
789
Xeris Biopharma Holdings
XERS
$1.26B
$23K ﹤0.01%
11,800
-1,952
-14% -$8.39K
TOTAR
790
DELISTED
Tottenham Acquisition I Limited Right expiring 3/6/2021
TOTAR
$22K ﹤0.01%
200,000
+25,000
+14% +$4.03K
VATE icon
791
INNOVATE Corp
VATE
$107M
$20K ﹤0.01%
+1,280
New +$36.9K
VIRX
792
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$20K ﹤0.01%
1,392
TOVX icon
793
Theriva Biologics
TOVX
$10.6M
$18K ﹤0.01%
225
-15
-6% -$1.71K
CREX icon
794
Creative Realities
CREX
$38M
$12K ﹤0.01%
5,311
-638
-11% -$2.66K
IZEA icon
795
IZEA Worldwide
IZEA
$60.9M
$12K ﹤0.01%
15,375
CSCI
796
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$12K ﹤0.01%
241
CREXW
797
DELISTED
Creative Realities, Inc. Warrant
CREXW
$10K ﹤0.01%
12,500
ALGRR
798
DELISTED
Allegro Merger Corp Right
ALGRR
$10K ﹤0.01%
110,300
AMPY icon
799
Amplify Energy
AMPY
$163M
$8K ﹤0.01%
+14,000
New +$61.2K
UWT
800
DELISTED
VelocityShares3x Long Crude Oil ETNs linked to the S&P GSCI Crude Oil Index ER
UWT
$5K ﹤0.01%
+28,500
New +$200K

Similar funds

Boothbay Fund Management's Q1 2020 Portfolio in Review

As of Q1 2020, Boothbay Fund Management held 1,231 positions worth $1.21B, up 5% from $1.15B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boothbay Fund Management deployed $88M of net new capital in Q1 2020, opening 406 new positions and adding to 209 existing holdings. Its largest new stake was Sprott Physical Gold: 1,601,344 shares worth $21M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was NXP Semiconductors, an estimated $6M trimmed.

  • Boothbay Fund Management's largest Q1 2020 buy was Sprott Physical Gold: 1,601,344 shares worth $21M.
  • Boothbay Fund Management added most to Allergan plc in Q1 2020, an estimated $37.1M increase.
  • Boothbay Fund Management's biggest Q1 2020 reduction was NXP Semiconductors, cutting an estimated $6M.
  • Boothbay Fund Management fully exited Sprott Physical Gold and Silver Trust in Q1 2020, selling an estimated $18.8M.
  • Boothbay Fund Management's ten largest holdings make up 18% of its $1.21B portfolio in Q1 2020.
  • Boothbay Fund Management opened 406 new positions and closed 411 in Q1 2020.
  • Boothbay Fund Management's portfolio value rose 5% quarter-over-quarter to $1.21B.

Based on Boothbay Fund Management's 13F filing for Q1 2020, filed 15 May 2020.